Clinical Cancer Research Journal Issues Research Articles in April 15, 2021 Edition
April 13, 2021
April 13, 2021
PHILADELPHIA, Pennsylvania, April 13 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its April 15, 2021 edition:
CCR Drug Updates:
* FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-posi . . .
CCR Drug Updates:
* FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-posi . . .